CytoSeek, a Bristol-based discovery-stage biotech company, has successfully secured funding of £3.5 million for the development of new cell therapies for cancer treatment. What do they do and why is it important to fund new research?
Over the last three years, We The Curious has been gathering questions from residents all over Bristol. With over 10,000 submissions from every postcode in the city, staff and volunteers whittled them down to just seven.
Academics from the University of Bristol have contributed to the development of a potential treatment for Diabetic Macular Oedema (DMO); an eye condition affecting more than 20 million diabetes patients.
Project MIMRee (Multi-Platform Inspection, Maintenance and Repair in Extreme Environments) was created in 2018 as part of an Innovate UK initiative, bridging together leading academics and industry experts including University of Bristol researchers.